TruSight Oncology

TruSight Oncology是一组用于检测癌症变异的NGS平台试剂,能使用基于富集的方法来同时分析DNA和RNA。不包含基因内容。Read More...
选择产品

TruSight® Oncology Library Prep

20010184

TruSight Oncology DNA Library Prep

20010185

TruSight® Oncology RNA Library Prep

20010186

TruSight® Oncology Enrichment

20010187

产品特色

The enrichment-based next-generation sequencing (NGS) reagents enable simultaneous analysis of DNA and RNA, and can cover a wide range of cancer variant types. The comprehensive nature of this methodology provides laboratories with a deep view into the genetics of cancer.

  • Accurate Results from Low-Quality Samples1
    Enables variant detection with as little as 40 ng DNA and RNA input, maximizing the results from precious formalin-fixed, paraffin-embedded (FFPE) samples.
  • Supports Comprehensive Coverage of Cancer-Related Variants
    Allows the assessment of multiple variant types in one assay using DNA and RNA which creates efficiencies in sample usage, time, and cost.
  • Integrated, Streamlined Workflow
    DNA and RNA are prepared in parallel with an integrated workflow following DNA shearing/cDNA synthesis.
  • Flexible Applications
    Enrichment-based workflow allows for a wide variety of content, input types, and applications.

Frequently Purchased Together

规格

Method-Specific Workflow Example

 

Feature Article

Genomics Powering Access to the Latest Cancer Breakthroughs

Garret Hampton discusses how TruSight Oncology can be extended to whole-exome and -genome sequencing and sequencing RNA transcripts for profiling of cancers.

Read More

Related Products

TruSight Tumor 170

全面的新一代测序(NGS)检测,靶定同一FFPE样本中的DNA和RNA变异。


TruSight RNA Fusion Panel

为福尔马林固定石蜡包埋(FFPE)样本和其他肿瘤研究样本提供了综合性基因融合检测方法。


TruSight Oncology 500

此分析方法靶向多种变异类型,包括肿瘤突变负荷(TMB)和微卫星不稳定性(MSI),即使是低质量样本同样适用。


References
  1. Data on file. Illumina, Inc. March 2017.